Mangalam Drugs' has fallen 37 percent since its high in December 8, 2015 and has been in lower circuit for the past 7 sessions. In an interview to CNBC-TV18, Govardhan Dhoot, MD, Mangalam Drugs Organic says the company is looking to increase its stake in the company from 42 percent to 52 percent.
Watch video for full interview.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!